Since the cGCM retains the natural NK cell membrane, it is likely to display these key recognition receptors (DNAM-1, NKG2D and NKp30), enabling ligand-receptor engagement with cancer cells and promoting enhanced proximity and interaction, as observed in our in vitro and in vivo models. This evidence concerns the gene CD226 and cancer.